On Thursday May 30th 2024, the FDA announced participation in three new collaborative communities in the medical device ecosystem, which included the Smart and Autonomous Medical Systems (SaAMS) Collaborative Community.
The FDA stated “A collaborative community is a continuing forum in which private- and public-sector members, which can include the FDA, work together on medical device challenges to achieve common objectives and outcomes. They are convened by interested stakeholders and may exist indefinitely, produce deliverables as needed, and tackle challenges with broad impacts.”
